The epiMelanoma test enables plasma-based detection of melanoma and prediction of immunotherapy response



Summary

The epiMelanoma test is a blood-based diagnostic tool offering a non-invasive method for melanoma detection and prediction of response to immunotherapy. This eliminates the need for invasive biopsies in some cases. By analyzing biomarkers in plasma, the test can identify the presence of melanoma and forecast how effectively a patient will respond to immunotherapy treatments. This allows for more personalized treatment plans and potentially better patient outcomes by enabling clinicians to make more informed decisions regarding treatment strategies for melanoma patients.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!